Back to Search Start Over

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana.

Authors :
Shava E
Izu A
Gaolathe T
Walker A
Carty L
Georgiou P
Kuate L
Kgathi C
Sekoto T
Seonyatseng N
Mogashoa T
Maphorisa C
Mohammed T
Ntalabgwe T
Frank TT
Matlhaku B
Diphoko A
Phindela T
Kaunda A
Kgari P
Kanyakula T
Palalani G
Phakedi I
Taylor S
Mmalane M
Moyo S
Makhema J
Source :
The Journal of infection [J Infect] 2023 Jun; Vol. 86 (6), pp. 603-606. Date of Electronic Publication: 2023 Mar 01.
Publication Year :
2023

Abstract

Competing Interests: Conflicts of interest ST and PG are employees of, and hold or may hold stock in, AstraZeneca. AW is an employee of X4 Group contracted to AstraZeneca for this work. LC is an employee of SRG Recruitment contracted to AstraZeneca for this work. All other authors declare that they have no conflict of interest.

Details

Language :
English
ISSN :
1532-2742
Volume :
86
Issue :
6
Database :
MEDLINE
Journal :
The Journal of infection
Publication Type :
Report
Accession number :
36863535
Full Text :
https://doi.org/10.1016/j.jinf.2023.02.037